Ryan William Stidham (Ryan W Stidham, R W Stidham)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Patients With Inflammatory Bowel Disease

Artificial Intelligence

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

Current gastroenterology reports

Digestive diseases and sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Mehwish Ahmed, Molly L Stone, Ryan William Stidham
Artificial Intelligence and IBD: Where are We Now and Where Will We Be in the Future? Current gastroenterology reports 26 (5) (2024)
Mehwish Ahmed, Molly L Stone, Ryan William Stidham
Artificial Intelligence and IBD: Where are We Now and Where Will We Be in the Future? Current gastroenterology reports (2024)
Mehwish Ahmed, Molly L Stone, Ryan William Stidham
Artificial Intelligence and IBD: Where are We Now and Where Will We Be in the Future? Current gastroenterology reports 26 (5) (2024)
Mehwish Ahmed, Molly L Stone, Ryan William Stidham
Artificial Intelligence and IBD: Where are We Now and Where Will We Be in the Future? Current gastroenterology reports 26 (5) (2024)
Mehwish Ahmed, Molly L Stone, Ryan William Stidham
Artificial Intelligence and IBD: Where are We Now and Where Will We Be in the Future? Current gastroenterology reports 26 (5) (2024)
Yanni Fan, Sílvia Delgado-Aros, Wendell C Valdecantos, Jud C Janak, Page C Moore, Margaux M Crabtree, Ryan William Stidham
Characteristics of Patients with Crohn's Disease With or Without Perianal Fistulae in the CorEvitas Inflammatory Bowel Disease Registry. Digestive diseases and sciences (2022)
Ryan William Stidham, Andrew Vickers, Karandeep Singh, Akbar K Waljee
From clinical trials to clinical practice: how should we design and evaluate prediction models in the care of IBD? Gut (2021)
Klaus Gottlieb, Marco Daperno, Keith Usiskin, Bruce E Sands, Harris A Ahmad, Colin W Howden, William Karnes, Young S Oh, Irene Modesto, Colleen Marano, Ryan William Stidham, Walter Reinisch
Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments. Gut 70 (2) (2020)
Andrew P Wright, Marc S Piper, Shrinivas Bishu, Ryan William Stidham
Letter: immune checkpoint inhibitor-induced colitis-shouldn't we be checking more often? Authors' reply. Alimentary pharmacology & therapeutics 50 (5) (2020)
Andrew P Wright, Marc S Piper, Shrinivas Bishu, Ryan William Stidham
Systematic review and case series: flexible sigmoidoscopy identifies most cases of checkpoint inhibitor-induced colitis. Alimentary pharmacology & therapeutics 49 (12) (2019)
Florian Rieders, D Bettenworth, C Ma, C E Parker, L A Williamson, S A Nelson, G van Assche, Antonio Di Sabatino, Y Bouhnik, Ryan William Stidham, Axel U Dignass, G Rogler, S A Taylor, J Stoker, J Rimola, M E Baker, J G Fletcher, J Panes, William J Sandborn, Brian G Feagan, V Jairath
An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease. Alimentary pharmacology & therapeutics 48 (3) (2018)
Mohamed Noureldin, Peter D R Higgins, Shail M Govani, Shirley Cohen-Mekelburg, Brooke C Kenney, Ryan William Stidham, Jennifer F Waljee, Akbar K Waljee
Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids. Alimentary pharmacology & therapeutics 49 (1) (2018)
Akbar K Waljee, B Liu, K Sauder, J Zhu, S M Govani, Ryan William Stidham, Peter D R Higgins
Predicting corticosteroid-free endoscopic remission with vedolizumab in ulcerative colitis. Alimentary pharmacology & therapeutics 47 (6) (2018)
Ryan William Stidham, A K Waljee
Editorial: visceral fat as a predictor of post-operative recurrence of Crohn's disease. Alimentary pharmacology & therapeutics 45 (12) (2017)